• Citer

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.

par Keymeulen, Bart;Candon, Sophie;Fafi-Kremer, Samira;Ziegler, Anette G;Leruez-Ville, Marianne;Mathieu, Chantal;Vandemeulebroucke, Evy;Walter, Markus;Crenier, Laurent ;Thervet, Eric;Legendre, Christophe;Pierard, Denis;Hale, Geoff;Waldmann, Herman;Bach, Jean-François;Seigneurin, Jean Marie;Pipeleers, Daniel;Chatenoud, Lucienne
Référence Blood, 115, 6, page (1145-1155)
Publication Publié, 2010-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.
Auteur:	Keymeulen, Bart; Candon, Sophie; Fafi-Kremer, Samira; Ziegler, Anette G; Leruez-Ville, Marianne; Mathieu, Chantal; Vandemeulebroucke, Evy; Walter, Markus; Crenier, Laurent; Thervet, Eric; Legendre, Christophe; Pierard, Denis; Hale, Geoff; Waldmann, Herman; Bach, Jean-François; Seigneurin, Jean Marie; Pipeleers, Daniel; Chatenoud, Lucienne
Informations sur la publication:	Blood, 115, 6, page (1145-1155)
Statut de publication:	Publié, 2010-02
Sujet CREF:	Allergie et immunopathologie
MeSH keywords:	Antibodies, Monoclonal -- therapeutic use
	Antigens, CD3 -- immunology
	B-Lymphocytes -- immunology
	DNA, Viral -- genetics
	Diabetes Mellitus, Type 1 -- immunology -- therapy -- virology
	Epstein-Barr Virus Infections -- immunology -- therapy -- virology
	Flow Cytometry
	Graft Survival -- immunology
	Herpesvirus 4, Human -- physiology
	Humans
	Kidney Transplantation
	Palatine Tonsil -- cytology
	Phenotype
	Placebos
	Polymerase Chain Reaction
	T-Lymphocytes -- immunology
	Viral Load
	Virus Activation
Note générale:	Clinical Trial, Phase II
	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0006-4971
	info:doi/10.1182/blood-2009-02-204875
	info:pii/blood-2009-02-204875
	info:scp/77949513969
	info:pmid/20007541